Join
Live feed
·
INSIDERFilingvia Quantisnow
Keros Therapeutics Inc. logo

Corp. Controller & VP, Finance Tanini Annita sold $12,595 worth of shares (1,224 units at $10.29), decreasing direct ownership by 3% to 45,144 units (SEC Form 4) (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KROS (Keros Therapeutics Inc.) and more on Quantisnow.